These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2602355)

  • 21. The use of undiluted amiodarone in the management of out-of-hospital cardiac arrest.
    Skrifvars MB; Kuisma M; Boyd J; Määttä T; Repo J; Rosenberg PH; Castren M
    Acta Anaesthesiol Scand; 2004 May; 48(5):582-7. PubMed ID: 15101852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Torsade de pointes during anti-arrhythmia treatment with amiodarone].
    Schlienger RG; Haefeli WE; Lüscher TF
    Schweiz Rundsch Med Prax; 1993 Feb; 82(6):173-5. PubMed ID: 7679520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amiodarone therapy for drug-refractory fetal tachycardia.
    Strasburger JF; Cuneo BF; Michon MM; Gotteiner NL; Deal BJ; McGregor SN; Oudijk MA; Meijboom EJ; Feinkind L; Hussey M; Parilla BV
    Circulation; 2004 Jan; 109(3):375-9. PubMed ID: 14732753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
    Ohnishi S; Kasanuki H
    J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacologic treatment for ventricular arrhythmias].
    Halawa B
    Pol Merkur Lekarski; 1997 Aug; 3(14):45-9. PubMed ID: 9480172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
    Raviele A; Di Pede F; Delise P; Piccolo E
    G Ital Cardiol; 1984 Sep; 14(9):644-54. PubMed ID: 6510619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of amiodarone in treatment of refractory atrial and ventricular tachyarrhythmias.
    Kato K
    Ann N Y Acad Sci; 1992 Jan; 644():235-45. PubMed ID: 1562118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous amiodarone for treating acute life threatening arrhythmias.
    Votey SR; Herbert ME
    West J Med; 1998 Mar; 168(3):183. PubMed ID: 9549418
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of amiodarone on stimulatory convertibility and degeneration into ventricular fibrillation of induced ventricular tachycardias in the pig].
    Hottinger S; Mettler D; Leupi F; Gertsch M
    Schweiz Med Wochenschr; 1985 Nov; 115(45):1594-6. PubMed ID: 4081686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of amiodarone in the treatment of ventricular tachycardia or ventricular fibrillation.
    Greene HL
    Prog Cardiovasc Dis; 1989; 31(5):319-54. PubMed ID: 2646655
    [No Abstract]   [Full Text] [Related]  

  • 31. Transient exacerbation followed by control of ventricular tachycardia with amiodarone.
    Mostow ND; Vrobel TR; Rakita L
    Am Heart J; 1986 Jan; 111(1):178-80. PubMed ID: 3946146
    [No Abstract]   [Full Text] [Related]  

  • 32. Intravenous amiodarone for short-term treatment of refractory ventricular tachycardia or fibrillation.
    Nalos PC; Ismail Y; Pappas JM; Nyitray W; DonMichael TA
    Am Heart J; 1991 Dec; 122(6):1629-32. PubMed ID: 1957758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous amiodarone for the rapid treatment of life-threatening ventricular arrhythmias in critically ill patients with coronary artery disease.
    Ochi RP; Goldenberg IF; Almquist A; Pritzker M; Milstein S; Pedersen W; Gobel FL; Benditt DG
    Am J Cardiol; 1989 Sep; 64(10):599-603. PubMed ID: 2782249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of electrophysiologic studies in predicting drug efficacy in patients receiving amiodarone.
    Somberg JC
    Am J Cardiol; 1987 Nov; 60(14):1218. PubMed ID: 3687772
    [No Abstract]   [Full Text] [Related]  

  • 35. [Long-term results of amiodarone therapy in patients with sustained ventricular tachycardia or ventricular fibrillation for prevention of cardiac sudden death].
    Kasanuki H; Inaba T; Ohnisi S; Shoda M; Matuda N; Hosoda S
    Jpn Circ J; 1994; 58 Suppl 4():1309-12. PubMed ID: 7699782
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapeutic decision in sustained ventricular tachycardia in patients with cardiomyopathy].
    Castro I
    Arq Bras Cardiol; 1990 Jun; 54(6):415-6. PubMed ID: 2288532
    [No Abstract]   [Full Text] [Related]  

  • 37. Human experience with amiodarone in the embryonic period.
    Ovadia M; Brito M; Hoyer GL; Marcus FI
    Am J Cardiol; 1994 Feb; 73(4):316-7. PubMed ID: 8093128
    [No Abstract]   [Full Text] [Related]  

  • 38. Amiodarone for sustained ventricular tachycardia: efficacy, safety, and factors influencing long-term outcome.
    Bauman JL; Berk SI; Hariman RJ; Langenberg PW; Deal BJ; Beckman K; Brownstein S; Gallastegui J
    Am Heart J; 1987 Dec; 114(6):1436-44. PubMed ID: 3687699
    [No Abstract]   [Full Text] [Related]  

  • 39. Amiodarone.
    N Engl J Med; 1987 Aug; 317(7):451-4. PubMed ID: 3614288
    [No Abstract]   [Full Text] [Related]  

  • 40. Is drug treatment of tachyarrhythmias a science or a lottery?
    Campbell RW
    Cardiologia; 1990 Jan; 35(1 Suppl):43-5. PubMed ID: 2128206
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.